Genetics and Treatment in Neurodegenerative Diseases
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Neurogenomics".
Deadline for manuscript submissions: 15 September 2025 | Viewed by 326
Special Issue Editors
Interests: Parkinson’s disease; neurodegeneration; neurogenetike; microglia; neuroimmunology
Interests: tandem repeat expansion disorders; hereditary ataxia; Huntington’s disease; whole genome sequencing; next-generation sequencing; RNA sequencing; Parkinson’s disease; neurodegenerative disorders
Special Issue Information
Dear Colleagues,
The Special Issue "Genetics and Treatment in Neurodegenerative Diseases" invites original research articles and comprehensive reviews exploring genetic determinants and therapeutic strategies in neurodegeneration. Manuscripts that focus on genetic factors contributing to diseases such as Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), and Huntington's disease are welcome, with an emphasis on insights that inform therapeutic innovation and personalized medicine. Submissions may include genetic association studies, pharmacogenomics, gene-editing therapies, biomarker identification, and translational research connecting genetics to clinical interventions, as well as novel genetic therapies. This issue aims to foster understanding of disease mechanisms, promote early diagnosis, and accelerate the development of targeted treatments, ultimately improving patient outcomes in neurodegenerative conditions.
Dr. Valentino Rački
Dr. Gaber Bergant
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegeneration
- genetics
- Alzheimer’s disease
- Parkinson’s disease
- gene therapy
- pharmacogenomics
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
